Acalabrutinib in treatment-naïve chronic lymphocytic leukemia: Mature results from phase II study demonstrating durable remissions and long-term tolerability.
暂无分享，去创建一个
J. Byrd | S. O'brien | J. Pagel | Jennifer R. Brown | N. Jain | W. Wierda | A. Hamdy | R. Furman | S. Devereux | P. Hillmen | D. Stephens | R. Izumi | P. Patel | J. Woyach | J. Barrientos | P. Martin | M. Wang